Restricted accessResearch articleFirst published online 2021-08
A Virtual Reality Serious Videogame Versus Online Chess Augmentation in Patients with Attention Deficit Hyperactivity Disorder: A Randomized Clinical Trial
Serious videogames and virtual reality (VR) have gained increasing interest for treating attention deficit hyperactivity disorder (ADHD). “The Secret Trail of Moon” (TSTM) study is a clinical trial devoted to testing the efficacy of TSTM, a VR serious videogame developed to train in five major cognitive skills usually compromised in patients with ADHD. This study is a three-arm nonequality trial comparing TSTM to online chess training and a control group (CG). This study aims to demonstrate that augmentation with either TSTM or online chess is efficacious in clinically drug-stable patients with ADHD.
Materials and Methods:
This study is prospective, unicentric, and randomized with a CG. One hundred five patients with ADHD, ages 12–22 years old, and pharmacologically stable were enrolled. Patients were randomized into three groups: TSTM group, online chess group (therapeutic chess [TC]), and CG. Objective and subjective measures of the patient and parents are included. Patient visits differ for each group. TSTM group patients have 15 face-to-face visits: preinclusion visit, inclusion visit, 12 training visits, and final visit. TC and CG patients have 3 face-to-face visits (preinclusion, initial visit, and final visit) and 12 e-mail or phone communications during training (TC) or follow-up (CG group). This study was approved by the local Institutional Review Board (IRB).
Results:
Not applicable. This is a study protocol.
Conclusion:
This is the first study testing an augmentation strategy using either a serious videogame or chess in clinically drug-treated patients with ADHD. Using VR serious videogames present with several advantages over traditional videogames.
Trial Registration: NCT04355065.
Get full access to this article
View all access options for this article.
References
1.
American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. DSM-5. Washington, DC: American Psychiatric Association; 2013.
2.
National Institute for Health and Clinical Excellence (NICE). Attention deficit hyperactivity disorder: Diagnosis and management. 2018. www.nice.org.uk/guidance/ng87 (accessed February11, 2021).
3.
Martínez-NúñezB, QuinteroJ. Update the Multimodal Treatment of ADHD (MTA): Twenty years of lessons. Actas Esp Psiquiatr, 2019; 47:16–22.
4.
PelhamWE, AltszulerAR. Combined treatment for children with attention-deficit/hyperactivity disorder: brief history, the multimodal treatment for attention-deficit/hyperactivity disorder study, and the past 20 years of research. J Dev Behav Pediatr, 2020; 41Suppl 2S:S88–S98.
5.
Rodríguez HernándezPJ, Criado GutiérrezI. [Multimodal treatment plan for ADHD. Psychoeducational treatment]. Pediatr Int, 2004; 624–633.
6.
CastellanosFX, LeePP, SharpW, et al.Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA, 2002; 288:1740–1748.
7.
ArnsM, HeinrichH, StrehlU. Evaluation of neurofeedback in ADHD: The long and winding road. Biol Psychol, 2014; 95:108–115.
8.
de Oliveira RosaV, Moreira-MaiaCR, WagnerF, et al.Computerized cognitive training for ADHD as an Add-on treatment to stimulants: A randomized clinical trial. J Atten Disord, 2021; 25:275–285.
9.
SiebelinkNM, BögelsSM, BoerboomLM, et al.Mindfulness for children with ADHD and Mindful Parenting (MindChamp): Protocol of a randomised controlled trial comparing a family Mindfulness-Based Intervention as an add-on to care-as-usual with care-as-usual only. BMC Psychiatry, 2018; 18:237.
10.
Fundació Sant Joan de Déu. [Working Group of the Clinical Practice Guideline on Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents. Quality Plan for the National Health System of the Ministry of Health, Social Policy and Equality]; 2010.
11.
Abad-MasL, Ruiz-AndrésR, Moreno-MadridF, et al.[Executive function training in attention deficit hyperactivity disorder]. Rev Neurol, 2011; 52Suppl 1:S77–S83.
12.
Blasco-FontecillaH, Gonzalez-PerezM, Garcia-LopezR, et al.Efficacy of chess training for the treatment of ADHD: A prospective, open label study. Rev Psiquiatr Salud Ment, 2016; 9:13–21.
13.
KimSH, HanDH, LeeYS, et al.Baduk (the Game of Go) improved cognitive function and brain activity in children with attention deficit hyperactivity disorder. Psychiatry Investig, 2014; 11:143–151.
14.
DemilyC, CavézianC, DesmurgetM, et al.The game of chess enhances cognitive abilities in schizophrenia. Schizophr Res, 2009; 107:112–113.
15.
GonçalvesPD, OmettoM, BecharaA, et al.Motivational Interviewing combined with chess accelerates improvement in executive functions in cocaine dependent patients: A one-month prospective study. Drug Alcohol Dep, 2014; 141:79–84.
16.
ArcherHA, SchottJM, BarnesJ, et al.Knight's move thinking? Mild cognitive impairment in a chess player. Neurocase, 2005; 11:26–31.
17.
AciegoR, GarcíaL, BetancortM. The benefits of chess for the intellectual and social-emotional enrichment in schoolchildren. Span J Psychol, 2012; 15:551–559.
18.
BulKCM, FrankenIHA, Van der OordS, et al.Development and user satisfaction of “Plan-It Commander,” a serious game for children with ADHD. Games Health J, 2015; 4:502–512.
19.
Taipe AlbánM. [Serious game model to improve attention in children with attention deficit hyperactivity disorder]. Rev Iberica Sist Technol Inform, 2019; (E17):936–946.
20.
Moreno GarcíaI, Delgado PardoG. [Neurofeedback and therapeutic adherence in ADHD]. Ann Psychol Clin Salud, 2013; 9:15–16.
21.
Schultheis MariaT, Rizzo AlbertA. The application of virtual reality technology in rehabilitation. Rehab Psychol, 2001; 46:296–311.
22.
BashiriA, GhazisaeediM, ShahmoradiL. The opportunities of virtual reality in the rehabilitation of children with attention deficit hyperactivity disorder: A literature review. Korean J Pediatr, 2017; 60:337–343.
23.
GorrindoT, GrovesJE. Computer simulation and virtual reality in the diagnosis and treatment of psychiatric disorders. Acad Psychiatry, 2009; 33:413–417.
24.
CostaRMEM, de CarvalhoLAV, DrummondR, et al.; Universidade Federal do Rio de Janeiro-Universidade do Estado do Rio de Janeiro Group. The UFRJ-UERJ group: Interdisciplinary virtual reality experiments in neuropsychiatry. Cyberpsychol Behav, 2002; 5:423–431.
25.
Maples-KellerJL, BunnellBE, KimS-J, RothbaumBO. The use of virtual reality technology in the treatment of anxiety and other psychiatric disorders. Harv Rev Psychiatry, 2017; 25:103–113.
26.
LevyF, RautureauG, JouventR. [Virtual reality therapy in the care management of anxiety disorders]. Vertex, 2018; 29:51–54.
27.
LognoulM, NaselloJ, TriffauxJ-M. [Virtual reality exposure therapy for post-traumatic stress disorders, obsessive-compulsive disorders and anxiety disorders: Indications, added value and limitations]. Encephale, 2020; 46:293–300.
28.
QueroS, MolésM, CamposD, et al.An adaptive virtual reality system for the treatment of adjustment disorder and complicated grief: 1-year follow-up efficacy data. Clin Psychol Psychother, 2019; 26:204–217.
29.
Mesa-GresaP, Gil-GómezH, Lozano-QuilisJ-A, Gil-GómezJ-A. Effectiveness of virtual reality for children and adolescents with autism spectrum disorder: An evidence-based systematic review. Sensors, 2018; 18:2486.
30.
YuanSNV, IpHHS. Using virtual reality to train emotional and social skills in children with autism spectrum disorder. London J Prim Care, 2018; 10:110–112.
31.
Shema-ShiratzkyS, BrozgolM, Cornejo-ThummP, et al.Virtual reality training to enhance behavior and cognitive function among children with attention-deficit/hyperactivity disorder: Brief report. Dev Neurorehabil, 2019; 22:431–436.
32.
Serra-PlaJF, PozueloM, RicharteV, et al.[Treatment of attention deficit hyperactivity disorder in adults using virtual reality through a mindfulness programme]. Rev Neurol, 2017; 64:S117–S122.
33.
BioulacS, Micoulaud-FranchiJ-A, MaireJ, et al.Virtual remediation versus methylphenidate to improve distractibility in children with ADHD: A controlled randomized clinical trial study. J Atten Disord, 2020; 24:326–335.
34.
ChoB-H, KimS, ShinDI, et al.Neurofeedback training with virtual reality for inattention and impulsiveness. Cyberpsychol Behav, 2004; 7:519–526.
35.
HudakJ, BlumeF, DreslerT, et al.Near-infrared spectroscopy-based frontal lobe neurofeedback integrated in virtual reality modulates brain and behavior in highly impulsive adults. Front Hum Neurosci, 2017; 11:425.
36.
BlumeF, HudakJ, DreslerT, et al.NIRS-based neurofeedback training in a virtual reality classroom for children with attention-deficit/hyperactivity disorder: Study protocol for a randomized controlled trial. Trials, 2017; 18:41.
37.
Rodrigo-YanguasM, Martin-MoratinosM, Gonzalez-TardonC, Blasco-FontecillaH. Virtual Reality and Chess. A Video Game for Cognitive Training in Patients with ADHD. Madrid,Spain: CEUR-WS; 2020, 2719.
38.
HalvorsenM, MathiassenB, AmundsenT, et al.Confirmatory factor analysis of the behavior rating inventory of executive function in a neuro-pediatric sample and its application to mental disorders. Child Neuropsychol, 2019; 25:599–616.
39.
López-VillalobosJA, Andrés-De LlanoJ, López-SánchezMV, et al.Criterion validity and clinical usefulness of Attention Deficit Hyperactivity Disorder Rating Scale IV in attention deficit hyperactivity disorder (ADHD) as a function of method and age. Psicothema Febrero De, 2017; 29:103–110.
40.
Vallejo-ValdivielsoM, SoutulloCA, de Castro-ManglanoP, Marín-MéndezJJ, Díez-SuárezA. Validation of a Spanish-language version of the ADHD Rating Scale IV in a Spanish sample. Neurologia, 2019; 34:563–572.
41.
SwansonJM, SchuckS, PorterMM, et al.Categorical and Dimensional Definitions and Evaluations of Symptoms of ADHD: History of the SNAP and the SWAN Rating Scales. Int J Educ Psychol Assess, 2012; 10:51–70.
42.
HallCL, GuoB, ValentineAZ, et al.The validity of the SNAP-IV in children displaying ADHD symptoms. Assessment, 2020; 27:1258–1271.
RoweKS, RoweKJ. Norms for parental ratings on Conners' Abbreviated Parent-Teacher Questionnaire: Implications for the design of behavioral rating inventories and analyses of data derived from them. J Abnorm Child Psychol, 1997; 25:425–451.
45.
UllmannRK, SleatorEK, SpragueRL. A change of mind: The Conners abbreviated rating scales reconsidered. J Abnorm Child Psychol, 1985; 13:553–565.
46.
Sánchez-SánchezF, LuqueT. [ATENTO, TEA Questionnaire for the assessment of executive functions and ADHD]. Madrid: TEA Ediciones; 2020.
47.
LuqueT, Sánchez-SánchezF. [Assessment of Executive Functions and ADHD: Reliability and validity of the ATENTO questionnaire in the Spanish population and preliminary studies in clinical sample]. Madrid: TEA Ediciones; 2018.
48.
EsnaolaI, FreemanJ, SarasaM, et al.Validity Evidence based on Internal Structure of Scores of the Emotional Quotient-Inventory: Youth Version Short (EQ-i: YV-S) in a Spanish Sample. Span J Psychol, 2016; 19:E12.
49.
Bar-OnR. The Bar-On model of emotional-social intelligence (ESI). Psicothema, 2006; 18Suppl:13–25.
50.
ShakedD, FaulknerLMD, TolleK, et al.Reliability and validity of the Conners' Continuous Performance Test. Appl Neuropsychol Adult, 2020; 27:478–487.
51.
WangL-J, LeeS-Y, TsaiC-S, et al.Validity of visual and auditory attention tests for detecting ADHD. J Atten Disord, 2021; 25:1160–1169.
52.
LambertTJR, CockN, AlcockSJ, et al.Measurement of antipsychotic-induced side effects: Support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement. Hum Psychopharmacol, 2003; 18:405–411.
53.
BusnerJ, TargumSD. The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry, 2007; 4:28–37.
54.
DuPaulGJ, FuQ, AnastopoulosAD, et al.ADHD parent and teacher symptom ratings: Differential item functioning across gender, age, race, and ethnicity. J Abnorm Child Psychol, 2020; 48:679–691.
55.
Bar-OnR, ParkerJDA. BarOn Emotional Quotient Inventory: Youth Version (BarOn EQ-i:YV). North Tonawanda,NY: Multi-Health Systems; 2000.
56.
LindströmE, LewanderT, MalmU, et al.Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nord J Psychiatry, 2001; 55Suppl 44:5–69.
57.
CohenJ. Statistical Power Analysis for the Behavioral Sciences. New York, Lawrence Erlbaum Associates, Publishers; 1988.
58.
SawilowskyS. New effect size rules of thumb. J Mod Appl Stat Methods, 2009; 8:467–474.
59.
DulcanM. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry, 1997; 36(10 Suppl): 85S–121S.
60.
ColemanB, MarionS, RizzoA, et al.Virtual reality assessment of classroom—Related attention: An ecologically relevant approach to evaluating the effectiveness of working memory training. Front Psychol, 2019; 10:1851.
61.
BarkleyRA. Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull, 1997; 121:65–94.
62.
ToplakME, BucciarelliSM, JainU, TannockR. Executive functions: Performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol, 2009; 15:53–72.
63.
ChoB-H, KuJ, JangDP, et al.The effect of virtual reality cognitive training for attention enhancement. Cyberpsychol Behav, 2002; 5:129–137.
64.
BrownM, O'NeillN, van WoerdenH, et al.Gamification and adherence to web-based mental health interventions: A systematic review. JMIR Ment Health, 2016; 3:e39.
65.
LauHM, SmitJH, FlemingTM, RiperH. Serious games for mental health: Are they accessible, feasible, and effective? A systematic review and meta-analysis. Front Psychiatry, 2016; 7:209.
66.
PrimackBA, CarrollMV, McNamaraM, et al.Role of video games in improving health-related outcomes: A systematic review. Am J Prev Med, 2012; 42:630–638.
67.
BuitelaarJK. Optimising treatment strategies for ADHD in adolescence to minimise “lost in transition” to adulthood. Epidemiol Psychiatr Sci, 2017; 26:448–452.
68.
Catalá-LópezF, HuttonB, Núñez-BeltránA, et al.The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: Protocol for a systematic review and network meta-analysis of randomized controlled trials. Syst Rev, 2015; 4:19.
69.
JohnsonSB, BlumRW, GieddJN. Adolescent maturity and the brain: The promise and pitfalls of neuroscience research in adolescent health policy. J Adolesc Health, 2009; 45:216–221.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
